Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy With EEG Extended With Intra-auricular Electrodes

Launched by PRZEMYSLAW KUNERT · Apr 10, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to help researchers find better ways to identify where seizures start in patients with drug-resistant temporal lobe epilepsy (TLE) and other types of epilepsy. The study will use a special monitoring technique called long-term video EEG (electroencephalogram) that includes traditional electrodes on the head as well as additional sensors placed in the ears. This combination aims to give doctors a clearer picture of the brain's activity during seizures and between seizures, which is important for planning effective treatments.

To participate in this trial, individuals must be at least 18 years old and have been diagnosed with epilepsy that does not respond to medication. They should also be able to cooperate with the use of the monitoring equipment and provide consent to take part in the study. However, people with certain conditions, such as those who have had previous brain surgery or have specific medical issues that could affect the results, may not be eligible. If you qualify, you'll undergo a monitoring process that allows doctors to gather important information about your seizures in a safe and supportive environment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \> 18 years
• • Diagnosis of drug-resistant epilepsy
• • Sufficient level of cooperation to use of the NAOX in-ear EEG system
• • Providing informed consent to participate in the study
• Exclusion Criteria:
• • Presence of skull bone defects, e.g. after prior neurosurgery
• • Presence of comorbidities that may significantly affect the resting EEG
• • Medical history strongly suggestive of psychogenic nonepileptic attacks